Department of Vascular Surgery, Aristotle University, Thessaloniki, Greece; Department of Research and Development, Dudley Group of Hospitals NHS Trust, Dudley, United Kingdom.
J Vasc Surg. 2013 Oct;58(4):879-85. doi: 10.1016/j.jvs.2013.03.036. Epub 2013 May 14.
Renal function may be associated with poor outcome following endovascular abdominal aortic aneurysm repair (EVAR), but this relationship has not been adequately investigated. The aim of this study is to evaluate the association of estimated glomerular filtration rate (eGFR) with cardiovascular events and all-cause mortality after EVAR.
Prospective cohort study of patients undergoing elective EVAR; eGFR was calculated using the Chronic Kidney Disease Epidemiology Collaboration formula, and patients were divided in four groups (eGFR ≥ 90 mL/min/1.73 m(2), group 1; 60-89, group 2; 30-59, group 3; <30, group 4). Composite end point consisted of death, nonfatal myocardial infarction, stroke, and vascular complications. Kaplan-Meier curves were constructed, and between-group comparisons were performed adjusted for variables that differed at baseline.
A total of 383 patients (mean age, 69 ± 8 years; mean abdominal aortic aneurysm diameter, 6.2 ± 1.4 cm) were included. Over a mean follow-up of 34 ± 12 months, the following events occurred: 20 deaths (5.2%), 15 nonfatal myocardial infarctions (3.9%), 9 nonfatal strokes (2.3%), and 7 peripheral vascular complications (1.8%). Patients with an eGFR <30 had the highest mortality (35%) and incidence of complications (80%) as per the end point (P = .009 and P < .001, respectively). Adjusted Cox-regression analysis showed that a higher eGFR at baseline by 1 mL/min/1.73 m(2) was associated with a 5% lower likelihood of complications as per the end point (P < .001; hazard ratio, 0.95; 95% confidence interval, 0.94-0.97) and a 6% lower likelihood of death (P < .001; hazard ratio, 0.94; 95% confidence interval, 0.92-0.97).
Impaired renal function is associated with an increase in cardiovascular events and mortality following elective EVAR.
肾功能可能与血管内腹主动脉瘤修复(EVAR)后的不良预后有关,但这一关系尚未得到充分研究。本研究旨在评估估算肾小球滤过率(eGFR)与 EVAR 后心血管事件和全因死亡率的关系。
前瞻性队列研究纳入接受择期 EVAR 的患者;使用慢性肾脏病流行病学合作公式计算 eGFR,并将患者分为四组(eGFR≥90 mL/min/1.73 m2,组 1;60-89,组 2;30-59,组 3;<30,组 4)。复合终点包括死亡、非致死性心肌梗死、卒中和血管并发症。构建 Kaplan-Meier 曲线,并对基线时存在差异的变量进行调整后进行组间比较。
共纳入 383 例患者(平均年龄 69±8 岁;平均腹主动脉瘤直径 6.2±1.4 cm)。平均随访 34±12 个月期间,发生以下事件:20 例死亡(5.2%),15 例非致死性心肌梗死(3.9%),9 例非致死性卒(2.3%)和 7 例外周血管并发症(1.8%)。eGFR<30 的患者死亡率(35%)和终点并发症发生率(80%)最高(P=0.009 和 P<0.001)。调整后的 Cox 回归分析显示,基线时 eGFR 每增加 1 mL/min/1.73 m2,终点并发症的可能性降低 5%(P<0.001;风险比,0.95;95%置信区间,0.94-0.97),死亡的可能性降低 6%(P<0.001;风险比,0.94;95%置信区间,0.92-0.97)。
肾功能受损与择期 EVAR 后心血管事件和死亡率增加相关。